Medical Aesthetics

Visionary Holdings experienced a significant revenue decline of 46.2% in FY2025 due to shifts in real estate and education, while its new health and aesthetics ventures began generating revenue. The company incurred a net loss of $15.75 million, partly from asset impairment, but saw improved gross margins and reduced operating cash outflows. Facing negative working capital and loan defaults, Visionary Holdings is pursuing equity financing and debt restructuring to support its pivot toward health management and premium medical aesthetics, with early market testing in Asia.

Visionary Holdings is pivoting to high-end medical aesthetics and anti-aging. This strategic shift includes new leadership, R&D collaborations, and a joint venture for an anti-aging center. The company aims to capitalize on market growth, with its annual report expected by January 12, 2026.

Baidu Health and the Chinese Association of Plastics and Aesthetics (CAPA) are partnering to improve medical aesthetics education. This collaboration aims to provide authoritative, comprehensive content, addressing misinformation and promoting a transparent industry. By leveraging their combined resources, they will offer reliable information through expert panels, AI tools, and verified resources, empowering consumers to make informed decisions and fostering a healthier medical aesthetics sector.